Results 91 to 100 of about 10,984 (251)

An Engineered Glove for the Objective Assessment of Hand Dexterity in Patients With Systemic Sclerosis

ACR Open Rheumatology, Volume 8, Issue 7, July 2026.
Objective Hand disability is a major musculoskeletal functional impairment in systemic sclerosis (SSc), but its objective assessment remains challenging. The validated Hand Test System (HTS) engineered glove has provided quantitative dexterity data in rheumatic diseases.
Alberto Sulli, Elvis Hysa, Paolo Clini, Emanuele Gotelli, Tamara Vojinovic, Carmen Pizzorni, Ali Jaffal, Sabrina Paolino, Rosanna Campitiello, Vanessa Smith, Maurizio Cutolo   +10 more
wiley   +1 more source

Raynaud's phenomenon in primary Sjogren's syndrome

, 1990
Our study describes the prevalence, clinical picture, course and sequelae of Raynaud's phenomenon in patients with primary Sjogren's syndrome. Furthermore, our study compares the clinical, serologic and immunogenetic profile of patients with Raynaud's ...
Skopouli, F. N., Talal, A., Galanopoulou, V., Drosos, A. A., Tsampoulas, C. G., Moutsopoulos, H. M.   +5 more
core  

Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenon

, 1994
Vasodilator function was determined in patients with Raynaud's phenomenon during intra-arterial infusions of the endothelium-dependent and -independent vasodilators, methacholine and sodium nitroprusside, respectively.
Khan, Faisel; id_orcid, Coffman, Jay D.
core   +1 more source

P149 An Exploratory Trial Assessing Finger Perfusion, Raynaud’s Condition Score and Safety, Following a Single Dose of CAM2043 (Treprostinil Subcutaneous Depot) in Patients with Raynaud's Phenomenon Secondary to Systemic Sclerosis [PDF]

, 2023
Ariane L. Herrick, Andrea Murray, Graham Dinsdale, Joanne Manning, Chukwuma Chukwu, Marcia Alvarez Fernandez, James R. Seibold, Fredrik Tiberg   +7 more
openalex   +1 more source

Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell–Targeted Therapies

Arthritis &Rheumatology, Volume 78, Issue 7, Page 1393-1402, July 2026.
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley   +1 more source

Calcium channel blockers for primary Raynaud's phenomenon.

, 2014
BACKGROUND: Calcium channel blockers are the most commonly prescribed drugs for people with primary Raynaud's phenomenon. Primary Raynaud's phenomenon is a common condition characterised by an exaggerated vasospastic response to cold or emotion ...
Marina E Anderson, Jack Wilkinson, Anderson, Marina E, Holly Ennis, Ariane L Herrick, Ennis, Holly, Wilkinson, Jack, Herrick, Ariane L   +7 more
core   +1 more source

Effects of Elevated CO2 on Bean Pod Mottle Virus Infection in Both Incompatible and Compatible Interactions With Phaseolus vulgaris L

Plant, Cell &Environment, Volume 49, Issue 7, Page 4493-4512, July 2026.
ABSTRACT Plant viruses cause significant crop losses, a situation that could worsen due to anthropogenic activities driving global climate change, one factor of which is the increase in atmospheric CO2 concentration. This study assessed the impact of elevated CO2 concentration (eCO2, 1000 vs. 400 ppm) on two genotypes of common bean (Phaseolus vulgaris
Tiffanie Scandolera, Julie Lintz, Ariane Gratias, Ellea Aboud, Simon Rochoux, Maria V. Préjean, Gilles Chatel Innocenti, Marie Garmier, Gianluca Teano, Juan C. Alvarez‐Diaz, Graham Noctor, Valérie Geffroy, Stéphanie Pflieger   +12 more
wiley   +1 more source

Flavouring Group Evaluation 216 Revision 3 (FGE.216Rev3): Consideration of the genotoxic potential of α,β‐unsaturated 2‐phenyl‐2‐alkenals from subgroup 3.3 of FGE.19

EFSA Journal, Volume 24, Issue 7, July 2026.
Abstract The EFSA Panel on Food Additives and Flavourings (FAF) evaluated the genotoxic potential of two flavouring substances, 2‐phenylcrotonaldehyde [FL‐no: 05.062] and 5‐methyl‐2‐phenylhex‐2‐enal [FL‐no: 05.099] from subgroup 3.3 of FGE.19, in the Flavouring Group Evaluation 216 revision 3 (FGE.216Rev3).
EFSA Panel on Food Additives and Flavourings (FAF), Laurence Castle, Monica Andreassen, Gabriele Aquilina, Maria Bastos, Polly Boon, Biagio Fallico, Rex FitzGerald, María José Frutos Fernández, Bettina Grasl‐Kraupp, Ursula Gundert‐Remy, Rainer Gürtler, Eric Houdeau, Marcin Kurek, Henriqueta Louro, Patricia Morales, Sabina Passamonti, Claudia Bolognesi, Eugenia Cordelli, Gisela Degen, Karl‐Heinz Engel, Maria Carfí, Alessandra Tosato, Carla Martino   +23 more
wiley   +1 more source

The concept of Raynaud's phenomenon of the lung revisited

, 1996
PURPOSE: Having observed that a cold presser test (CPT) induces a decrease in carbon monoxide single breath diffusing capacity (DLco) in normal subjects contrary to the findings of Fahey et al (Am J Med.
Charloux, A, Lonsdorfer, J., Frans, Albert, Lampert, E.   +3 more
core   +1 more source

Fenómeno de Raynaud Raynaud's Phenomenon

Angiologia e Cirurgia Vascular, 2011
O Fenómeno de Raynaud (FR) é uma manifestação clínica comum, traduzida por vasoespasmos recorrentes dos dedos, na maioria das vezes provocados pela exposição ao frio ou estímulos emocionais. Pode ser primário (idiopática) ou secundária a diversas doenças
Ivone Silva, Tiago Loureiro, Isabel Almeida, Armando Mansilha, Rui Almeida, Carlos Vasconcelos   +5 more
doaj